Brain MR Imaging Findings in Woodhouse-Sakati Syndrome

References

1. 1.↵
   2. Woodhouse NJ,
   3. Sakati NA

   . A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness, and ECG abnormalities. J Med Genet 1983;20:216–19 doi:10.1136/jmg.20.3.216 pmid:6876115

   Abstract/FREE Full Text
2. 2.↵
   1. Adam MP,
   2. Ardinger HH,
   3. Pagon RA, et al.

   2. Bohlega SA,
   3. Alkuraya FS

   . Woodhouse-Sakati syndrome. 2016 Aug 4. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK378974/. Accessed May 16, 2018.
3. 3.↵
   2. Alazami AM,
   3. Schneider SA,
   4. Bonneau D, et al

   . C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients. Clin Genet 2010;78:585–90 doi:10.1111/j.1399-0004.2010.01441.x pmid:20507343

   CrossRefPubMed
4. 4.↵
   2. Al-Semari A,
   3. Bohlega S

   . Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1. Am J Med Genet Part A 2007;143A:149–160
5. 5.↵
   2. Schneider SA,
   3. Bhatia KP

   . Dystonia in the Woodhouse Sakati syndrome: a new family and literature review. Mov Disord 2008;23:592–96 doi:10.1002/mds.21886 pmid:18175354

   CrossRefPubMed
6. 6.↵
   2. Abdulla MC,
   3. Alazami AM,
   4. Alungal J, et al

   . Novel compound heterozygous frameshift mutations of C2orf37 in a familial Indian case of Woodhouse-Sakati syndrome. J Genet 2015;94:489–92 doi:10.1007/s12041-015-0544-7 pmid:26440089

   CrossRefPubMed
7. 7.↵
   2. Koshy G,
   3. Danda S,
   4. Thomas N, et al

   . Three siblings with Woodhouse-Sakati syndrome in an Indian family. Clin Dysmorphol 2008;17:57–60 doi:10.1097/MCD.0b013e3282beb59e pmid:18049083

   CrossRefPubMed
8. 8.↵
   2. Habib R,
   3. Basit S,
   4. Khan S, et al

   . A novel splice site mutation in gene C2orf37 underlying Woodhouse-Sakati syndrome (WSS) in a consanguineous family of Pakistani origin. Gene 2011;490:26–31 doi:10.1016/j.gene.2011.09.002 pmid:21963443

   CrossRefPubMed
9. 9.↵
   2. Hdiji O,
   3. Turki E,
   4. Bouzidi N, et al

   . Woodhouse-Sakati syndrome: report of the first Tunisian family with the C2orf37 gene mutation. J Mov Disord 2016;9:120–23 doi:10.14802/jmd.16003 pmid:27240811

   CrossRefPubMed
10. 10.↵
    2. Rachmiel M,
    3. Bistritzer T,
    4. Hershkoviz E, et al

    . Woodhouse-Sakati syndrome in an Israeli-Arab family presenting with youth-onset diabetes mellitus and delayed puberty. Horm Res Paediatr 2011;75:362–66 doi:10.1159/000323441 pmid:21304230

    CrossRefPubMed
11. 11.↵
    2. Steindl KL,
    3. Alazami AM,
    4. Bhatia KP, et al

    . A novel C2orf37 mutation causes the first Italian cases of Woodhouse Sakati syndrome. Clin Genet 2010;78:594–97 doi:10.1111/j.1399-0004.2010.01447.x pmid:21044051

    CrossRefPubMed
12. 12.↵
    2. Alazami AM,
    3. Al-Saif A,
    4. Al-Semari A, et al

    . Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet 2008;83:684–91 doi:10.1016/j.ajhg.2008.10.018 pmid:19026396

    CrossRefPubMed
13. 13.↵
    2. Agopiantz M,
    3. Corbonnois P,
    4. Sorlin A, et al

    . Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature. J Endocrinol Invest 2014;37:1–7 doi:10.1007/s40618-013-0001-5 pmid:24464444

    CrossRefPubMed
14. 14.↵
    2. Kruer MC,
    3. Boddaert N,
    4. Schneider A, et al

    . Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012;33:407–14 doi:10.3174/ajnr.A2677 pmid:21920862

    Abstract/FREE Full Text
15. 15.↵
    2. Comella CL,
    3. Leurgans S,
    4. Wuu J, et al

    ; Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18:303–12 doi:10.1002/mds.10377 pmid:12621634

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Schiffmann R,
    3. van der Knaap MS

    . Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009;72:750–59 doi:10.1212/01.wnl.0000343049.00540.c8 pmid:19237705

    Abstract/FREE Full Text
17. 17.↵
    2. McLachlan MS,
    3. Williams ED,
    4. Fortt RW, et al

    . Estimation of pituitary gland dimensions from radiographs of the sella turcica: a post-mortem study. Br J Radiol 1968;41:323–30 doi:10.1259/0007-1285-41-485-323 pmid:5647993

    Abstract/FREE Full Text
18. 18.↵
    2. Doraiswamy PM,
    3. Potts JM,
    4. Axelson DA, et al

    . MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol 1992;13:1295–99 pmid:1414818

    Abstract/FREE Full Text
19. 19.↵
    2. Kwee RM,
    3. Kwee TC

    . Virchow-Robin spaces at MR imaging. Radiographics 2007;27:1071–86 doi:10.1148/rg.274065722 pmid:17620468

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Murray RA,
    3. Maheshwari HG,
    4. Russell EJ, et al

    . Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. AJNR Am J Neuroradiol 2000;21:685–89 pmid:10782778

    Abstract/FREE Full Text
21. 21.↵
    2. Mehmood S,
    3. Hoggard N,
    4. Hadjivassiliou M

    . Gordon Holmes syndrome: finally genotype meets phenotype. Pract Neurol 2017;17:476–78 doi:10.1136/practneurol-2017-001674 pmid:28972031

    Abstract/FREE Full Text
22. 22.↵
    2. Synofzik M,
    3. Gonzalez MA,
    4. Lourenco CM, et al

    . PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain 2014;137:69–77 doi:10.1093/brain/awt326 pmid:24355708

    CrossRefPubMed
23. 23.↵
    2. Salvador F,
    3. Garcia-Arumí J,
    4. Corcóstegui B, et al

    . Ophthalmologic findings in a patient with cerebellar ataxia, hypogonadotropic hypogonadism, and chorioretinal dystrophy. Am J Ophthalmol 1995;120:241–44 doi:10.1016/S0002-9394(14)72612-1 pmid:7639308

    CrossRefPubMed
24. 24.↵
    2. Malhotra HS,
    3. Garg RK,
    4. Vidhate MR, et al

    . Boomerang sign: clinical significance of transient lesion in splenium of corpus callosum. Ann Indian Acad Neurol 2012;15:151–57 doi:10.4103/0972-2327.95005 pmid:22566735

    CrossRefPubMed
25. 25.↵
    2. Bulakbasi N,
    3. Kocaoglu M,
    4. Tayfun C, et al

    . Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006;27:1983–86 pmid:17032879

    Abstract/FREE Full Text
26. 26.↵
    2. van der Knaap MS,
    3. Valk J,
    4. de Neeling N, et al

    . Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 1991;33:478–93 doi:10.1007/BF00588038 pmid:1780048

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Bobele GB,
    3. Garnica A,
    4. Schaefer GB, et al

    . Neuroimaging findings in Alexander's disease. J Child Neurol 1990;5:253–58 doi:10.1177/088307389000500321 pmid:2398241

    CrossRefPubMedWeb of Science
28. 28.↵
    2. van der Knaap MS,
    3. Smit LM,
    4. Barth PG, et al

    . Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997;42:50–59 doi:10.1002/ana.410420110 pmid:9225685

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Schmahmann JD,
    3. Smith EE,
    4. Eichler FS, et al

    . Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci 2008;1142:266–309 doi:10.1196/annals.1444.017 pmid:18990132

    CrossRefPubMedWeb of Science
30. 30.↵
    2. van der Knaap MS,
    3. Naidu S,
    4. Breiter SN, et al

    . Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001;22:541–52 pmid:11237983

    Abstract/FREE Full Text
31. 31.↵
    2. Arber CE,
    3. Li A,
    4. Houlden H, et al

    . Review: insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation—unifying theories. Neuropathol Appl Neurobiol 2016;42:220–41 doi:10.1111/nan.12242 pmid:25870938

    CrossRefPubMed
32. 32.↵
    2. Hogarth P

    . Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 2015;8:1–13 doi:10.14802/jmd.14034 pmid:25614780

    CrossRefPubMed
33. 33.↵
    2. Almeqdadi M,
    3. Kemppainen JL,
    4. Pichurin PN, et al

    . Phenotypic variability of c.436delC DCAF17 gene mutation in Woodhouse-Sakati syndrome. Am J Case Rep 2018;19:347–53 doi:10.12659/AJCR.907395 pmid:29574468

    CrossRefPubMed